Work

LB0004 Paediatric Systemic Lupus Erythematosus (pSLE) patient stratification and high-performance serum biomarkers identified responders to statin and patients with high cardiovascular risk in the APPLE trial (Atorvastatin for Atherosclerosis Progression in Paediatric Systemic Lupus Erythematosus)

Year: 2023

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2023-eular.7032

Authors: C. Ciurtin, J. Peng, P. Donnes, L. Lewandowski, S. Ardoin, L. Schanberg, G. Robinson, E. Jury

Institutions: University College London, National Institutes of Health, Nationwide Children's Hospital, Duke University

Language: English

Topic: Systemic Lupus Erythematosus Research

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Bristol-Myers Squibb, Eli Lilly and Company, Pfizer, AstraZeneca, GlaxoSmithKline, Sanofi, CSL Behring, Horizon Therapeutics, Swedish Orphan Biovitrum

OpenAlex ID: W4379521458

Cites:

Cited by:

Related to: 10